GlycoMimetics
GLYC
#10327
Rank
NZ$17.53 M
Marketcap
NZ$0.27
Share price
-5.42%
Change (1 day)
-44.88%
Change (1 year)

GlycoMimetics (GLYC) - Cash on Hand

Cash on Hand as of March 2025 : NZ$9.71 Million

According to GlycoMimetics 's latest financial reports the company has NZ$9.71 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

GlycoMimetics - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$19 M-71.24%
2023-12-31NZ$66.08 M-12.35%
2022-12-31NZ$75.39 M-42.94%
2021-12-31NZ$0.13 B-30.43%
2020-12-31NZ$0.18 B-19.15%
2019-12-31NZ$0.23 B-24.94%
2018-12-31NZ$0.31 B79.35%
2017-12-31NZ$0.17 B201.86%
2016-12-31NZ$57.8 M-15.47%
2015-12-31NZ$68.38 M-2.93%
2014-12-31NZ$70.45 M2405.55%
2013-12-31NZ$2.81 M-86.69%
2012-12-31NZ$21.11 M-41.5%
2011-12-31NZ$36.09 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
bluebird bio
BLUE
NZ$0.13 B 1,302.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$25.93 B 266,795.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$18.09 B 186,069.33%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
NZ$32.13 B 330,526.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ$4.36 M-55.11%๐Ÿ‡บ๐Ÿ‡ธ USA